Wall Street analysts’ average price target implies 59.7% upside for Profound Medical (PROF), with the article also citing a favorable trend in earnings estimate revisions. The piece is cautiously constructive, though it notes that price targets are an imperfect signal. Overall impact is limited but potentially supportive for the stock.
Wall Street analysts’ average price target implies 59.7% upside for Profound Medical (PROF), with the article also citing a favorable trend in earnings estimate revisions. The piece is cautiously constructive, though it notes that price targets are an imperfect signal. Overall impact is limited but potentially supportive for the stock.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
mildly positive
Sentiment Score
0.35
Ticker Sentiment